Issue 5 2021

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition:

  • Ethics (CPD) – Increased empathy means better care
  • Oncology (CPD) – Diagnosis of Neuroendocrine tumours (NETs)
  • Cardiology – ESC 2021 Heart failure guideline update
  • Podiatry (CPD) – Managing onychomycosis needs patience and persistence
  • … and many more !

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online

Hyaluronic Acid Pushes Back against Osteoarthritis

Hyaluronic Acid Pushes Back against Osteoarthritis

Osteoarthritis (OA) is a chronic degenerative joint disease characterised by progressive damage of articular cartilage and underlying bone. It is a common rheumatic disease that affects both genders, especially in older people. Several clinical trials have shown that hyaluronic acid reduces arthritic pain in osteoarthritis of the knee with significant improvements in pain and physical function. It has an excellent tolerability profile with a low incidence of local complications and absence of systemic effects.

Modern Medicine – Issue 5 2021

Ménière’s Disease Weighs Heavily on Patients

Ménière’s Disease Weighs Heavily on Patients

Ménière’s disease (MD) is a clinical condition defined by spontaneous vertigo attacks (each lasting 20 minutes to 12 hours). It also presents with fluctuating aural symptoms (hearing loss, tinnitus, or ear fullness) in the affected ear. The diagnosis of MD is typically not made at a single point in time; rather, it may take months or even years to fully appreciate the clinical manifestations leading to a definitive diagnosis.

Modern Medicine – Issue 5 2021

SABA Alone no Longer Recommended for Asthma Management

SABA Alone no Longer Recommended for Asthma Management

The Global Initiative for Asthma (GINA) critically revises evidence on asthma management yearly and provides a structured set of recommendations. The 2020 GINA Report maintains a major change in the management recommendations, which were introduced in 2019, in relation to pharmacological treatment. GINA no longer recommends treatment of asthma in adults and adolescents with short-acting beta-2 agonists alone.

Modern Medicine – Issue 5 2021

Manifesto on United Airways Diseases (UAD) An Interasma (Global Asthma Association) Document

Manifesto on United Airways Diseases (UAD) An Interasma (Global Asthma Association) Document

The large amount of evidence and the renewed interest in upper and lower airways involvement in infectious and inflammatory diseases has led Interasma (Global Asthma Association) to take a position on United Airways Diseases (UAD). Patients with UAD need to have a timely and adequate diagnosis, treatment, and, when recommended, referral for management in a specialised centre. Diagnostic testing including skin prick or serum specific IgE, lung function, fractional exhaled nitric oxide (FeNO), polysomnography, allergen-specific immunotherapies, biological therapies and home based continuous positive airway pressure whenever these are recommended, should be part of the management plan for UAD. This is a shortened version of the original article.

Modern Medicine – Issue 5 2021

In Vitro IgE Testing Helps to Diagnose Allergies

In Vitro IgE Testing Helps to Diagnose Allergies

Allergic diseases are amongst the most prevalent diseases worldwide and the burden of these diseases continues to increase. An accurate diagnosis coupled with optimal therapy requires the use of appropriate tests to confirm the allergen sensitisation and detailed information about exposure to the putative allergen. Currently, testing for immunoglobulin E (IgE) sensitisation is the cornerstone of diagnostic evaluation in suspected allergic conditions.

Modern Medicine – Issue 5 2021

Progestogens Help Manage Menstrual Disorders

Progestogens Help Manage Menstrual Disorders

The use of progesterone and synthetic analogues, the progestogens, in abnormal (dysfunctional) uterine bleeding (AUB) and menstrual disorders including menopausal hormone replacement, is well established. AUB is defined as menstrual bleeding of abnormal amount, duration or schedule. It is common, and accounts for one in three gynaecology clinic visits.1 Dydrogesterone therapy has been shown to be effective in achieving menstrual cycle regularity with neutral effects on sex hormones.

Modern Medicine – Issue 5 2021

Safety of Azelaic Acid for Treating Acne during Pregnancy

Safety of Azelaic Acid for Treating Acne during Pregnancy

Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit and is characterised by noninflammatory (comedones) and inflammatory lesions (papules, pustules, and nodules) that can cause scarring and psychological distress. In women who are planning pregnancy or who are pregnant, this condition can be particularly bothersome given the physiologic changes as well as the unpredictable nature of acne during this time. Azelaic acid shows benefits in the treatment of patients with acne vulgaris, rosacea, and perioral dermatitis.

Modern Medicine – Issue 5 2021

Managing Onychomycosis Needs Patience and Persistence

Managing Onychomycosis Needs Patience and Persistence

Onychomycosis is an infection of the nail unit caused by fungi (dermatophytes, non-dermatophyte molds and yeasts), presenting with discoloration of the nail, onycholysis, and nail plate thickening. Onychomycosis is the most common disorder affecting the nail unit and accounts for at least 50% of all nail diseases. Current treatment modalities of onychomycosis include oral antifungal therapies, topical antifungal therapies, and device-based therapies, alone or in combination.

Modern Medicine – Issue 5 2021

Microbial-binding Woundcare A Strategy to Lift Bioburden

Microbial-binding Woundcare A Strategy to Lift Bioburden

Wounds can be a source of infection by allowing unrestricted entry of microorganisms into the body, including antimicrobial-resistant bacteria. The use of wound dressings that irreversibly bind and remove microbes using their natural hydrophobic properties minimises cell destruction and the resulting release of damaging endotoxins and offers a novel approach that supports antimicrobial stewardship strategies.

Modern Medicine – Issue 5 2021